semaglutide injections miami Weight Loss Miami, FL |

MASH resolution without worsening of fibrosis: 2.4 mg dose: 47% of participants (vs 14% placebo) 4.8 mg dose: 62% of participants (vs 14% placebo) 6.0 mg dose: 43% of participants (vs 14% placebo) Liver fat reduction of at least 30%: 2.4 mg dose: 63% of participants 4.8 mg dose: 67% of participants 6.0 mg dose: 57% of participants Placebo: 14% of participants Fibrosis improvement by at least one stage: Survodutide groups: 34-36% Placebo: 22% The percentage change from baseline in liver fat content after 48 weeks was a staggering 62% reduction in the 6.0 mg group, compared to just 5.7% in the placebo group

While Ozempic (semaglutide) is not indicated to treat psoriasis directly, emerging evidence suggests its anti-inflammatory properties may provide benefits independent of weight loss alone

Tesamorelin-Specific Considerations Tesamorelin can mildly elevate fasting glucose and HbA1c in some patients

This focus addresses a critical gap in the literature, as previous research has primarily centered on patients with type 2 diabetes